Hide Board Information

Show Board Information

BorrowMoney.com inc. BWMY

Board Mod: Add me as mod

Asst Mods:

Last Post: 09/17/2024 5:06:04 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

BorrowMoney.com inc. (OTCMRKTS: BWMY) Stock Message Board

1. BWMY Company Profile

    

2. BWMY Time & Sales

    

3. BWMY Recent News

    

4. BWMY Filings

    

5. BWMY Financials

    

6. BWMY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1

BWMY, SEC delinquent. Pink to Expert Market,

Steel Reserve

09/17/2024 5:06:04 PM

Top 10 Most Recent News Articles

Groundbreaking Delaware Legislation Aims to Combat Lyme Disease

Category: News Total Views: 1

By : Ryan Hughes Updated: 10-31-2024

Delaware's Initiative Against Lyme Disease In a significant advancement in public health, US Biologic, Inc., Global Lyme Alliance (GLA), and the Center for Lyme Action (CLA) are celebrating the recent passage of a key legislative bill aimed at combating Lyme disease. This newly established law includes a dedicated fund for interventions and aims to significantly reduce the prevalence of Lyme disease on state-owned lands, ensuring the safety of the public. Understanding the Bi... Continue Reading

PDS Health Highlights the Vital Role of Dental Hygienists

Category: News Total Views: 1

By : Riley Hayes Updated: 10-31-2024

PDS Health Highlights the Vital Role of Dental Hygienists National Dental Hygiene Month is a special time to honor and celebrate the essential contributions of dental hygienists in enhancing patients' oral and systemic health. PDS Health, a prominent dental and medical support organization, proudly recognizes this month dedicated to appreciating the vital role dental hygienists play in improving patients' health outcomes. This annual observance brings awareness to the crucial ... Continue Reading

ESSA Pharma Ends Phase 2 Trial of Masofaniten and Enzalutamide

Category: News Total Views: 22

By : Lucas Young Updated: 10-31-2024

Understanding ESSA Pharma's Recent Clinical Trial Decision ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company dedicated to developing innovative therapies for prostate cancer, has recently announced the termination of a crucial Phase 2 clinical trial. This trial evaluated the efficacy of masofaniten in combination with enzalutamide in patients suffering from metastatic castration-resistant prostate cancer (mCRPC) who had not previously undergone treatment with s... Continue Reading

Embracing the Harmony of Cultures in One Road by BRI Band

Category: News Total Views: 19

By : Addison Perry Updated: 10-31-2024

Exploring One Road: A Melodic Journey of UnityRecently, the BRI Band released a vibrant new song titled One Road, captivating listeners with its enthralling blend of cultures and languages. This uplifting tune, created by talented international students at Nanchang Hangkong University, showcases how music transcends borders and unites people from various backgrounds.The Essence of the SongThe song begins with the powerful lyrics, "I come from Africa, you come f... Continue Reading

DermRays Unveils Innovative Men's Hair Removal Device

Category: News Total Views: 19

By : Riley Hayes Updated: 10-31-2024

DermRays Is Preparing for a Game-Changing Product Launch DermRays is thrilled to introduce a revolutionary hair removal device tailored specifically for men. This new product targets the growing demand among male users seeking effective grooming solutions in their daily routines. Set to arrive in summer 2025, this cutting-edge device will boast a unique design along with upgraded features that enhance the grooming experience for its users. Addressing Men's Grooming Needs... Continue Reading

Dollar Stability: Impacts of US Jobs and Political Climate

Category: News Total Views: 17

By : Kelly Martin Updated: 10-31-2024

Understanding the Current State of the DollarThe dollar has shown steady performance against its major counterparts recently. Investors are closely watching the U.S. jobs report, which is pivotal for assessing the economy's strength before the upcoming Federal Reserve monetary policy meeting and a consequential presidential election.The Influence of the U.S. Jobs ReportAs we transition into November, the dollar began the month with some downward pressure, particularly... Continue Reading

ChromaDex Corporation Achieves Record Growth in Q3 2024

Category: News Total Views: 19

By : Thomas Cooper Updated: 10-31-2024

ChromaDex Corporation Reports Impressive Financial Results for Q3 2024 ChromaDex Corp. (NASDAQ:CDXC) has released its financial results for the third quarter of 2024, showcasing robust growth across various metrics. The Los Angeles-based bioscience company has made significant strides in its revenue generation, customer outreach, and product innovation. Financial Highlights Overview During the third quarter of 2024, ChromaDex achieved total net sales amounting to $25... Continue Reading

Ampco-Pittsburgh Unveils Third Quarter Earnings Call Details

Category: News Total Views: 19

By : Ryan Hughes Updated: 10-31-2024

Ampco-Pittsburgh Announces Third Quarter Earnings Conference Call Ampco-Pittsburgh Corporation (NYSE: AP) is set to hold a conference call to discuss their financial results for the third quarter. This event is scheduled for Tuesday morning at 10:30 a.m. Eastern Time (ET). The call will provide insights into the company's performance for the quarter ending September 30. Participation Details for the Conference Call Participants who wish to join the call can do so by r... Continue Reading

Vacasa's Upcoming Financial Update: What to Expect This Quarter

Category: News Total Views: 19

By : Dominic Sanders Updated: 10-31-2024

Vacasa to Announce Third Quarter Financial Results Vacasa (Nasdaq: VCSA), recognized as North America's premier vacation rental management platform, is gearing up to share its financial performance for the third quarter of 2024. The announcement is scheduled to take place after the market closes, providing valuable insights into the company's operations and future outlook. Key Details of the Announcement The financial results will be released on a Thursday at 2:00 p.m... Continue Reading

Vir Biotechnology Shares Third Quarter Insights and Updates

Category: News Total Views: 18

By : Olivia Taylor Updated: 10-31-2024

Vir Biotechnology Announces Key Q3 2024 Developments Vir Biotechnology, Inc. (NASDAQ: VIR) has shared significant updates regarding its performance and strategies following a transformative third quarter in 2024. With a commitment to addressing pressing health challenges, the company has enhanced its clinical pipeline with several innovative therapies and made pivotal organizational changes. Updates on Clinical Pipeline Programs Vir has been making strides in its cli... Continue Reading

More News Articles

Recent Articles

• Mynaric AG Faces Class Action: Investors Urged to Take Action
• Groundbreaking Delaware Legislation Aims to Combat Lyme Disease
• PDS Health Highlights the Vital Role of Dental Hygienists
• ESSA Pharma Ends Phase 2 Trial of Masofaniten and Enzalutamide
• Embracing the Harmony of Cultures in One Road by BRI Band
• DermRays Unveils Innovative Men's Hair Removal Device
• Dollar Stability: Impacts of US Jobs and Political Climate
• ChromaDex Corporation Achieves Record Growth in Q3 2024
• Ampco-Pittsburgh Unveils Third Quarter Earnings Call Details
• Vacasa's Upcoming Financial Update: What to Expect This Quarter
• Vir Biotechnology Shares Third Quarter Insights and Updates
• Sabra Health Care REIT's Quarterly Results and 2024 Outlook
• AXT, Inc. Reports Impressive Q3 2024 Results and Outlook
• Onto Innovation Shows Strong Financial Growth in Q3 2024
• Grid Dynamics Achieves Record Growth in Q3 2024 Results
• D-Wave Quantum Announces Q3 2024 Financial Results Schedule
• Entravision Sets Earnings Call for Q3 2024 Financials Release
• Comtech Reports Strong Fourth Quarter Results for 2024
• Julia Roberts Sparks Debate with Vote Kamala Harris Ad
• SES AI Corporation Reveals Q3 2024 Financial Insights
• Eagle Bancorp Announces Participation in Key Financial Conference
• Marchex Reveals Q3 2024 Financial Performance Insights
• Eastman Chemical Company Reports Strong Third-Quarter Growth
• Capstone Copper Achieves Major Growth in Q3 2024 Financials
• United States Steel Corporation's Q3 2024 Performance Insights
• Ontrak Health Announces Q3 2024 Financial Results Date
• Olympic Steel Unveils Q3 2024 Financial Performance Highlights
• Raising Awareness for Familial Hypercholesterolemia with ABC
• Tidewater Inc. Plans Earnings Call for Upcoming Financial Results
• Nine Energy Service Surpasses Revenue Expectations in Q3 2024
• Surf Air Mobility's Financial Update Scheduled for November 2024
• Frontier Communications to Share Q3 2024 Earnings Soon
• Alliant Energy's Q3 2024 Financial Performance Revealed
• South Korea's Manufacturing Sector Faces Continued Contraction
• Japan's Manufacturing Sector Faces Significant Decline in Output
• Trinseo Scheduling Key Financial Results Conference Call
• Sierra Metals Reports Impressive Q3 2024 Financial Results
• Traffic Sensors Market to Experience Significant Growth Ahead
• Strategic Investment by Northfield Capital in Hemlo Explorers
• Eagle Bancorp to Showcase Strategies at Financial Conference
• Pangea Laboratory Partners with Unilabs for Cancer Assay in Europe
• Australian Central Bank's Interest Rate Strategy Insights
• Eloro Resources Secures $3.78 Million in Latest Placement
• CCR Reports Impressive Growth and Operational Highlights
• Levine Leichtman Capital Partners Celebrated as Top Investor
• Ignacio del Pino Takes Charge as New Chief Investment Officer
• CCR Reports 3rd Quarter Growth and Future Plans
• Cathie Wood's ARK ETFs Make Strategic Moves with Stocks
• U.S. Dollar's Continued Strength Amid Economic Performance Insights
• Hemlo Explorers Secures Funding for Major Exploration Projects
• Tiffany Haddish Set to Emcee Stand Together Event in November
• Eisai Moves Forward with LEQEMBI for Alzheimer’s Care
• Daiso Celebrates New Store Opening with Exciting Promotions
• Mynaric AG Faces Investigation Amid Securities Fraud Claims
• Exploring Sustainable Urban Futures: World Cities Day 2024
• Portnoy Law Firm Investigates Customers Bancorp for Fraud
• Eisai Advances Leqembi BLA Submission for Home Administration
• Eisai Advances Alzheimer's Treatment with Leqembi Dosing Submission
• New Trade Opportunities for New Zealand with Gulf Cooperation Council
• Exploring Healing Through Movement: Human Garage & W.O.W.
• Newbury Street II Acquisition Corp. Prices $150M IPO with Nasdaq Listing
• Lavoro Limited Financial Insights: Q4 2024 Earnings Report
• Investors Encouraged to Lead Class Action Against WM Technology
• Robert Half's Recognition for Championing Women's Workplace Success
• Union Calls for Boycott of Bigfoot Beverages Amid Strike
• Eupraxia Pharmaceuticals Secures C$44.5 Million Through Shares
• Elon Musk's $56 Billion Tesla Compensation Controversy Unfolds
• Washington Residents Reported Cases of Bird Flu in Oregon
• Lavoro Limited Posts Fourth Quarter FY2024 Earnings Review
• Daiso Celebrates Grand Opening in Texas with Special Events
• Brookfield Strengthens Corporate Structure for Shareholder Value
• Mount Logan Capital Acquires Stake in Runway Growth Capital
• Investors Urged to Pay Attention Ahead of New Fortress Lawsuit
• Black Diamond Group's Q3 2024 Review: Revenue and Growth Insights
• Brookfield Transitions to Strengthen Management and Equity Growth
• Investors May Join WEBTOON Entertainment Lawsuit for Justice
• Czech Leaders Commemorate Russian Political Prisoners Today
• Sperra, Fraunhofer IEE, and PLEUGER Unite for Energy Innovation
• Natural Grocers Welcomes Richard Hallé as New CFO
• Iran's Tensions Drive Oil Prices Higher Amid Regional Conflict
• AiCuris Launches Promising Phase 1 Study for BK Virus Treatment
• Salem Media Group and Breitbart Launch Exciting New Podcast
• Haymarket Media Group Appoints Dana DiFerdinando to Board
• Claranova Unveils Its Comprehensive FY 2023-2024 Document
• Brookfield's Strategic Move to Restructure Corporate Holdings
• Sarepta Therapeutics Announces New Equity Grants for Employees
• Bleichroeder Acquisition Corp. I Successfully Prices IPO Offering
• Tractor Supply Company Gears Up for Investment Community Day
• Lexicon Pharmaceuticals Updates on Zynquista and FDA Meeting Outcome
• Ikonisys SA Reveals Robust Growth in Latest Financial Update
• Black Diamond Group Achieves Key Milestones in Q3 2024
• Lomiko Metals Moves Forward with Share Issuance to Settle Debts
• Investigation Launched Into Evolv Technologies Holdings, Inc.
• Intuit Set to Reveal First Quarter Results for 2025 Fiscal Year
• Medpace Holdings Faces Investigation Amid Revenue Guidance Cuts
• UWM Holdings Corporation Set for Third Quarter Earnings Call
• University of Phoenix Leaders Highlight Inclusive Education Strategies
• Exploring Cannabis Consumption Trends in Various Industries
• AM Best Panel Webinar Highlights Opportunities in Title Insurance
• Investors Urged to Act Ahead of Class Action Deadline for GitLab